Price
$35.23-18.82%Social Signal Score
Analyst Ratings
19 analystsRevenue
$7.86B+27.02%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- James Boyle
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 45,000
- Beta
- -0.39
- Country
- US
- Piotroski score
- 8 / 9 (Strong)
- Altman Z-score
- 2.15
Financials
MDLN has only 9 quarterly periods on file — the charts below show the full history available.
Revenue
$7.86B+27.0%Net Income
$195.00M-33.2%EBITDA
$810.00M+0.5%Free Cash Flow
$884.00M+43.7%EPS (diluted)
$0.22-40.5%Shares Outstanding (diluted)
1.32B+67.2%Operating Expenses
$1.26BCash & Debt
$3.61BReturn of Capital
$0.00Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $28.43B | $1.16B | $1.43 |
| 2024 | $25.51B | $1.20B | $1.52 |
| 2023 | $23.23B | $234.00M | $0.30 |
| 2022 | $21.45B | $-25.00M | $-0.03 |
Valuation
Project earnings forward and see what return today's price implies.
EPS was negative in at least one boundary year, so a compound growth rate can't be computed from it. Set your own assumption.
- EPS in 5 years
- $2.10
- Implied price
- $60.82
- Return from $37.84
- 10.0% a year
To earn 15.0% a year on these assumptions you'd need to buy at $30.24 — -20.1% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 21 | 25 | 29 | 33 | 37 |
|---|---|---|---|---|---|
| -2.0% | -6.5% | -3.1% | -0.2% | 2.4% | 4.8% |
| 3.0% | -1.7% | 1.8% | 4.9% | 7.6% | 10.1% |
| 8.0% | 3.1% | 6.7% | 10.0% | 12.8% | 15.4% |
| 13.0% | 7.9% | 11.7% | 15.0% | 18.1% | 20.8% |
| 18.0% | 12.6% | 16.6% | 20.1% | 23.3% | 26.1% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
78+159.26%Social Signal Score
Mentions (37)
- News (RSS)investing·4d ago·Neutral
Medline stock falls as shareholders price secondary offering
View source ↗ - News (RSS)zerohedge·4d ago·Neutral
… ties. Citigroup and JPMorgan added language to financing documents for a potential loan making the borrower responsible for complying with chip-access restrictions. Medline backers including Blackstone and Carlyle raised $2.1 billion in a share sale priced at $35.50, Applied Optoelectronics slides 11% after unveiling a $550 million at-the-market stock offering, and Tencent's Q3 revenue of 207.3 billion yuan missed estimates as AI spending squeezed profit.Investors woke up to relief rather than …
View source ↗ - News (RSS)investing·4d ago·Neutral
Medline stockholders price secondary offering at $35.50
View source ↗ - News (RSS)zerohedge·6d ago·Neutral
…tes, on the same weekend SpaceX caught its Starship upper stage midair for the first time; Summit Therapeutics plunges after the FDA declined to approve ivonescimab; Medline holders filed to offer 60 million shares; and US airlines are still digging out after an FAA network outage, with cancellations topping 17,000.Global markets open the week in risk-off mode, with nerves on edge ahead of three big catalysts: Nvidia earnings and the Anthropic IPO will test the AI trade, retail sales and big-box…
View source ↗ - Newsglobenewswire.com·11d ago·Negative
MDLN Securities Notice: Medline Investors that Suffered Losses when Stock Plummeted 13% are Notified to Contact BFA Law about its Securities Fraud Investigation NEW YORK, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://ww…
View source ↗ - News (RSS)seekingalpha·18d ago·Neutral
Medline outlines 2027 high single-digit net sales growth while launching a $1B share repurchase program
View source ↗ - News (RSS)seekingalpha·18d ago·Positive
Medline Inc. (MDLN) Q3 2026 Earnings Call Transcript
View source ↗ - News (RSS)investing·18d ago·Neutral
Medline Q3 2026 slides: sales rise 10%, shares jump 15% on guidance
View source ↗ - News (RSS)seekingalpha·18d ago·Positive
Medline posts best intraday gain after Q3 beat, $1B share buybacks
View source ↗ - Newsmarketbeat.com·18d ago·Positive
Medline Q3 Earnings Call Highlights Medline NASDAQ: MDLN reported third-quarter revenue growth of 10% year over year to $7.9 billion, supported by broad-based gains across its Medline Brand and Supply Chain Solutions businesses. Adjusted EBITDA increased 12% to $1 billion, while the company raised its full-year organic sales growth outlook for a third consecutive quarter.
View source ↗ - Newszacks.com·18d ago·Neutral
Medline (MDLN) Reports Q3 Earnings: What Key Metrics Have to Say While the top- and bottom-line numbers for Medline (MDLN) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
View source ↗ - Newsglobenewswire.com·18d ago·Neutral
Medline Reports Third Quarter and Nine Months 2026 Results NORTHFIELD, Ill., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline” or the “Company”) (Nasdaq: MDLN), the largest provider of medical-surgical (“med-surg”) products and supply chain solutions serving all points of care3, today reported its operating results for the three and nine months ended September 26, 2026.
View source ↗ - Newsglobenewswire.com·18d ago·Negative
MDLN Investigation Reminder: Medline Product Quality Issues Trigger Securities Fraud Investigation for Investors – Contact BFA Law if You Lost Money NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com…
View source ↗ - Newsglobenewswire.com·23d ago·Negative
MDLN Stock Market Alert: Medline Under Investigation for Potential Securities Fraud Over Product Quality Issues – Contact BFA Law if You Lost Money NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/c…
View source ↗ - Newsglobenewswire.com·25d ago·Negative
$MDLN Stock Market Alert: Medline Investigated for Securities Fraud after Product Quality Issues Lead to 13% Stock Drop – Contact BFA Law if You Lost Money NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfa…
View source ↗ - Newsprnewswire.com·30d ago·Neutral
Medline hosts fourth annual MedTrans Rodeo in Mundelein, Ill. /PRNewswire/ -- Medline's private fleet of truck drivers, MedTrans, recently completed its fourth annual National Truck Rodeo, which celebrates the drivers'
View source ↗ - Newsglobenewswire.com·30d ago·Negative
MDLN Investigation News: Medline Investors are Notified of the Pending Securities Fraud Investigation – Contact BFA Law if You Lost Money NEW YORK, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/medli…
View source ↗ - Newsglobenewswire.com·32d ago·Negative
MDLN Loss Notice: Medline Investors are Reminded of the Pending Securities Fraud Investigation – Contact BFA Law if You Lost Money NEW YORK, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/medline-cla…
View source ↗ - Newsglobenewswire.com·34d ago·Negative
MDLN Investigation Reminder: Medline Investors that Lost Money after the 13% Stock Drop are Notified to Contact BFA Law NEW YORK, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/medline-class-action-la…
View source ↗ - News (RSS)seekingalpha·37d ago·Neutral
Medline to construct new distribution facility near Detroit
View source ↗ - News (RSS)investing·38d ago·Neutral
Medline plans 800,000 sq ft distribution center in Michigan
View source ↗ - Newsprnewswire.com·38d ago·Neutral
Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich. State-of-the-art facility planned to reinforce Medline's supply chain resilience in Michigan NORTHFIELD, Ill., Oct. 15, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN), the largest provider of medical-surgical products and supply chain solutions serving all points of care, has announced plans to open a new distribution center in Van Buren Township, Mich.
View source ↗ - Newsglobenewswire.com·39d ago·Negative
$MDLN Investors: A Securities Fraud Investigation is Pending on behalf of Medline Investors that Lost Money after 13% Stock Drop – Contact BFA Law NEW YORK, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/c…
View source ↗ - Newsprnewswire.com·40d ago·Negative
MDLN Stock Alert: Medline Product Quality Issues and Subsequent 13% Stock Drop Trigger Securities Fraud Investigation for Investors BFA Law is investigating whether Medline Inc. committed securities fraud relating to statements about Medline's manufacturing and product quality. NEW YORK, Oct. 13, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ: MDLN) for potential securities fraud after its significant stock drops.
View source ↗ - News (RSS)investing·41d ago·Neutral
Medline launches enhanced inventory management system for care facilities
View source ↗ - Newsprnewswire.com·41d ago·Neutral
…entory tracking with PointClickCare® integration to reduce manual work and improve supply visibility NORTHFIELD, Ill., Oct. 12, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN) today announced the launch of an enhanced version of TrackPoint™, its online inventory management and patient item usage solution designed to help long-term care and inpatient hospice providers more easily track supplies from Medline, capture patient-level usage and gain visibility into inventory across locations.
View source ↗ - Newsglobenewswire.com·44d ago·Negative
MDLN Securities Alert: Lose Money on Your Medline Investment? BFA Law Notifies Investors of the Ongoing Securities Fraud Investigation over Product Quality Issues NEW YORK, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://w…
View source ↗ - Newsglobenewswire.com·46d ago·Negative
MDLN Investor Reminder: BFA Law Reminds Medline Investors that Lost Money when Stock Dropped 13% of the Ongoing Securities Fraud Investigation NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases…
View source ↗ - Newsglobenewswire.com·47d ago·Neutral
Medline to report third quarter 2026 results on November 4, 2026 NORTHFIELD, Ill., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report third quarter 2026 financial results on Wednesday, November 4, 2026. A press release and supplemental materials will be issued before the market opens. The company will host a webcast and conference call at 9:30am ET/ 8:30am CT to discuss the financial results.
View source ↗ - Newsprnewswire.com·47d ago·Negative
MDLN Stock Notice: Medline Stock Plummeted 13% after Product Quality Issues Disclosed - Securities Fraud Investigation Underway BFA Law is investigating whether Medline Inc. committed securities fraud relating to statements about Medline's manufacturing and product quality. NEW YORK, Oct. 6, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ: MDLN) for potential securities fraud after its significant stock drops.
View source ↗ - Newsglobenewswire.com·48d ago·Negative
MDLN Investigation Notification: Medline is Under Investigation for Securities Fraud over Product Quality Issues – Contact BFA Law if You Suffered Losses NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops. If you invested in Medline securities, you are encouraged to obtain additional information by visiting: https://www.bfala…
View source ↗ - Newsglobenewswire.com·58d ago·Negative
MDLN Stock Drop Alert: Medline Stock Plummets 13% after Product Quality Issues Revealed – BFA Law Notifies Investors of its Ongoing Securities Fraud Investigation NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops.
View source ↗ - Newsglobenewswire.com·60d ago·Negative
$MDLN Stock Notification: Medline Inc. is Being Investigated for Securities Fraud after Product Quality Issues Disclosed – Investors are Alerted to Contact BFA Law NEW YORK, Sept. 23, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock drops.
View source ↗ - Newsbusinesswire.com·61d ago·Negative
MDLN Stock Drop Alert: Medline Inc.'s Stock Drops 13% over Product Quality Issues Triggering Securities Fraud Investigation by BFA Law NEW YORK--(BUSINESS WIRE)---- $MDLN #BFA--Medline Inc.'s Stock Drops 13% over Product Quality Issues Triggering Securities Fraud Investigation by BFA Law.
View source ↗ - News (RSS)businessinsider·67d ago·Negative
Kaplan Fox Alerts Investors of Medline Inc. (MDLN) to a Securities Law Investigation <img src="https://api.newsfilecorp.com/newsinfo/314588/208" id="208" width="2" height="2" style="width: 1px; height: 1px;border: 0px solid;">New York, New York--(Newsfile Corp. - September 16, 2026) - <a href="https://api.newsfilecorp.com/redirect/Gz3EbTWR1P" rel="noopener nofollow" target="_blank">Kaplan Fox Kilsheimer LLP</a> is...
View source ↗ - News (RSS)businessinsider·97d ago·Negative
Kaplan Fox & Kilsheimer LLP is Investigating Medline Inc. (MDLN) for Possible Securities Law Violations <img src="https://api.newsfilecorp.com/newsinfo/309916/208" id="208" width="2" height="2" style="width: 1px; height: 1px;border: 0px solid;">New York, New York--(Newsfile Corp. - August 17, 2026) - <a href="https://api.newsfilecorp.com/redirect/RYmYGfwX2x" rel="noopener nofollow" target="_blank">Kaplan Fox Kilsheimer LLP</a> is investigating...
View source ↗ - News (RSS)businessinsider·100d ago·Negative
Kaplan Fox Reminds Medline Inc. (MDLN) Investors of an Investigation into Potential Securities Law Violations <img src="https://api.newsfilecorp.com/newsinfo/309091/208" id="208" width="2" height="2" style="width: 1px; height: 1px;border: 0px solid;">New York, New York--(Newsfile Corp. - August 14, 2026) - <a href="https://api.newsfilecorp.com/redirect/wELgrSrGbK" rel="noopener nofollow" target="_blank">Kaplan Fox Kilsheimer LLP</a> is investigating...
View source ↗
Earnings
Wed, Feb 24(in 3 months)
Consensus estimate $0.39 per share
Typical surprise +20.0% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Nov 4$0.44 vs $0.34beat
- Wed, Aug 5$0.50 vs $0.35beat
- Wed, May 6$0.33 vs $0.30beat
- Wed, Feb 25$0.22 vs $0.24miss
Estimates and results for MDLN via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by MDLN officers and directors.
No open-market trades in the recent filings. All 100 recent Form 4 entries were share awards, option exercises or tax withholding — pay, not decisions to buy or sell.
100 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in MDLN.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
